701 related articles for article (PubMed ID: 34390376)
21. Varicella-zoster virus.
Arvin AM
Clin Microbiol Rev; 1996 Jul; 9(3):361-81. PubMed ID: 8809466
[TBL] [Abstract][Full Text] [Related]
22. Vaccine-derived varicella zoster infection in a kidney transplant recipient after zoster vaccine live administration.
Ortiz-Brizuela E; Leal-Vega F; Cuellar-Rodríguez J; Bobadilla-Del-Valle M; Ponce-de-León A
Vaccine; 2019 Jun; 37(27):3576-3579. PubMed ID: 31109718
[TBL] [Abstract][Full Text] [Related]
23. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
[TBL] [Abstract][Full Text] [Related]
24. Real-world evidence from over one million COVID-19 vaccinations is consistent with reactivation of the varicella-zoster virus.
Hertel M; Heiland M; Nahles S; von Laffert M; Mura C; Bourne PE; Preissner R; Preissner S
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):1342-1348. PubMed ID: 35470920
[TBL] [Abstract][Full Text] [Related]
25. Neonatal vaccine-strain varicella-zoster virus infection 22 days after maternal postpartum vaccination.
Kluthe M; Herrera A; Blanca H; Leung J; Bialek SR; Schmid DS
Pediatr Infect Dis J; 2012 Sep; 31(9):977-9. PubMed ID: 22572750
[TBL] [Abstract][Full Text] [Related]
26. Primary varicella zoster infection compared to varicella vaccine reactivation associated meningitis in immunocompetent children.
Amaral V; Shi JZ; Tsang AM; Chiu SS
J Paediatr Child Health; 2021 Jan; 57(1):19-25. PubMed ID: 33295075
[TBL] [Abstract][Full Text] [Related]
27. Varicella-zoster virus infection: natural history, clinical manifestations, immunity and current and future vaccination strategies.
Freer G; Pistello M
New Microbiol; 2018 Apr; 41(2):95-105. PubMed ID: 29498740
[TBL] [Abstract][Full Text] [Related]
28. Clinical and molecular pathogenesis of varicella virus infection.
Gilden DH; Cohrs RJ; Mahalingam R
Viral Immunol; 2003; 16(3):243-58. PubMed ID: 14583142
[TBL] [Abstract][Full Text] [Related]
29. Varicella zoster virus reactivation following COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: A cross-sectional Chinese study of 318 cases.
Chen J; Li F; Tian J; Xie X; Tang Q; Chen Y; Ge Y
J Med Virol; 2023 Jan; 95(1):e28307. PubMed ID: 36372774
[TBL] [Abstract][Full Text] [Related]
30. Advances in the treatment of varicella-zoster virus infections.
Andrei G; Snoeck R
Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
[TBL] [Abstract][Full Text] [Related]
31. Pole-to-pole involvement of varicella zoster virus reactivation following COVID-19 vaccination.
Mahendradas P; Parmar Y; Mishra SB; Patil A; Kawali A; Sanjay S; Shetty B
Indian J Ophthalmol; 2023 May; 71(5):2001-2007. PubMed ID: 37203073
[TBL] [Abstract][Full Text] [Related]
32. Varicella zoster virus-induced neurological disease after COVID-19 vaccination: a retrospective monocentric study.
Abu-Rumeileh S; Mayer B; Still V; Tumani H; Otto M; Senel M
J Neurol; 2022 Apr; 269(4):1751-1757. PubMed ID: 34724572
[TBL] [Abstract][Full Text] [Related]
33. Varicella zoster virus reactivation following COVID-19 vaccination: a report of 3 cases.
Saraiva AL; Vieira AR; Marinho MC; Zadorozhnya O
Fam Pract; 2022 Sep; 39(5):939-942. PubMed ID: 35244157
[TBL] [Abstract][Full Text] [Related]
34. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
35. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child.
Kramer JM; LaRussa P; Tsai WC; Carney P; Leber SM; Gahagan S; Steinberg S; Blackwood RA
Pediatrics; 2001 Aug; 108(2):E39. PubMed ID: 11483849
[TBL] [Abstract][Full Text] [Related]
36. [Reactivation of herpes zoster infection by varicella-zoster virus].
Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
[TBL] [Abstract][Full Text] [Related]
37. Perspectives on vaccines against varicella-zoster virus infections.
Gershon AA; Gershon MD
Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
[TBL] [Abstract][Full Text] [Related]
38. Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults.
Gelb LD; Dohner DE; Gershon AA; Steinberg SP; Waner JL; Takahashi M; Dennehy PH; Brown AE
J Infect Dis; 1987 Apr; 155(4):633-40. PubMed ID: 3029239
[TBL] [Abstract][Full Text] [Related]
39. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature.
David DS; Tegtmeier BR; O'Donnell MR; Paz IB; McCarty TM
Am J Gastroenterol; 1998 May; 93(5):810-3. PubMed ID: 9625133
[TBL] [Abstract][Full Text] [Related]
40. Live attenuated varicella vaccine.
Arvin AM; Gershon AA
Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
